Lower dementia risk with different classes of antihypertensive medication in older patients

Tessa van Middelaar1, Lonneke A van Vught, Eric P Moll van Charante

  • 1aDepartment of Neurology, Academic Medical Center (AMC), Amsterdam bDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen cDepartment of General Practice, Amsterdam Public Health Research Institute dDepartment of Internal Medicine, Academic Medical Center (AMC), Amsterdam, the Netherlands.

Insights

Antihypertensive medications (AHMs) like calcium channel blockers (CCBs) and angiotensin receptor blockers (ARBs) may reduce dementia risk in older adults. This study found CCBs and ARBs were independently associated with a decreased risk of dementia.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Neurology

Background:

  • Antihypertensive medication (AHM) use is linked to reduced dementia risk.
  • Calcium channel blockers (CCBs) and angiotensin receptor blockers (ARBs) are hypothesized to offer greater protection.

Purpose of the Study:

  • To investigate the association between different classes of AHM and dementia risk in older individuals.
  • To compare dementia incidence among users of various AHM classes.

Main Methods:

  • Analysis of a subgroup of community-dwelling older adults from the 'Prevention of Dementia by Intensive Vascular Care' trial.
  • Comparison of incident dementia rates based on AHM classes (monotherapy and combination therapy) versus other AHMs.

Main Results:

  • 1951 participants used AHM; 136 developed dementia over 6.7 years.
  • Use of CCBs (HR 0.56) and ARBs (HR 0.60) was independently associated with decreased dementia risk.
  • CCB association was strongest in those without cardiovascular disease history and with uncontrolled hypertension.

Conclusions:

  • CCBs and ARBs are independently associated with a reduced risk of dementia in older adults.
  • These findings support the potential neuroprotective role of specific antihypertensive drug classes.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
792
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
303
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.0K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.5K